Article
Discovery of WS-384, a first-in-class dual LSD1 and DCN1-UBC12 protein-protein interaction inhibitor for the treatment of non-small cell lung cancer (NSCLC)
2023-02-20
Abstract excerpt
<title>Abstract</title> <p>Abnormally high expression of lysine-specific demethylase 1A (LSD1) and DCN1 plays a vital role in the occurrence, development, and poor prognosis of non-small cell lung cancer (NSCLC). Accumulating evidence has shown that the development of small-molecule inhibitors dually targeting LSD1 and the UBC12-DCN1 interaction probably have therapeutic promise for cancer therapy. This work repo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d5e68a31-b529-5d30-9c18-b47325e4730b
- DOI
- 10.21203/rs.3.rs-2593334/v1
